Arshad Khan

Arshad Khan is a highly experienced scientist currently serving as a Scientist IV at Boehringer Ingelheim and as a Biology Scientist In Vitro at Pfizer since March 2023 and November 2022, respectively. With a strong background in assay development and data analysis for pharmacodynamics studies, Arshad has contributed significantly to cross-functional collaboration. Previously, experience includes an Assistant Professor role at Houston Methodist, focusing on molecular and cell-based assays related to tuberculosis vaccine research, and similar academic positions at UTHealth, where emphasis was placed on vaccine development and immunopathogenesis studies. Education includes a PhD in Biotechnology from the National Chemical Laboratory, an MSc in Microbiology from MDS University, and a BSc in Chemistry, Botany, and Zoology from Dungar College.